Clinical Scorecard: The Latest in Keratoconus Treatment
At a Glance
| Category | Detail |
|---|---|
| Condition | Keratoconus |
| Key Mechanisms | Progressive degenerative disease of the cornea leading to steepening, thinning, and irregular astigmatism. |
| Target Population | Typically presents in the second or third decade of life; prevalence estimated at 1:2000. |
| Care Setting | Optometry and ophthalmology clinics. |
Key Highlights
- Corneal crosslinking is the gold standard for limiting progression.
- Scleral lenses have improved vision correction for keratoconus patients.
- Early treatment is crucial to prevent progression and optimize vision.
- New surgical techniques like CAIRS and CTAK offer less invasive options.
- Epi-on crosslinking is under investigation to reduce complications.
Guideline-Based Recommendations
Diagnosis
- Early identification of keratoconus by optometrists and ophthalmologists.
Management
- Corneal crosslinking to halt progression.
- Use of scleral lenses for vision correction.
Monitoring & Follow-up
- Regular follow-ups to assess corneal shape and vision.
Risks
- Corneal transplantation carries significant risks; crosslinking may not improve vision.
Patient & Prescribing Data
Patients with keratoconus, particularly those in early stages.
Combination of crosslinking and scleral lenses can significantly improve quality of life.
Clinical Best Practices
- Initiate treatment early to prevent progression.
- Consider scleral lenses for patients with irregular corneas.
- Evaluate new surgical techniques for patients unable to wear contact lenses.
References
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.